Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Harlow, SP; Krag, DN
   Sentinel lymph node - Why study it: Implications of the B-32 study
   SEMINARS IN SURGICAL ONCOLOGY
   
   S.P. Harlow e D.N. Krag, "Sentinel lymph node - Why study it: Implications of the B-32 study", SEM SURG ON, 20(3), 2001, pp. 224-229
2. Sakai, T; Kamohara, T; Aiba, S; Yoshioka, T; Itinohe, A; Chiba, H; Watanabe, T; Linuma, K
   Efficacy of early piston-type high-frequency oscillatory ventilation in infants with respiratory distress syndrome
   PEDIATRIC PULMONOLOGY
   
   T. Sakai et al., "Efficacy of early piston-type high-frequency oscillatory ventilation in infants with respiratory distress syndrome", PEDIAT PULM, 32(2), 2001, pp. 168-174
3. Sokol, GM; Fineberg, NS; Wright, LL; Ehrenkranz, RA
   Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide
   PEDIATRIC PULMONOLOGY
   
   G.M. Sokol et al., "Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide", PEDIAT PULM, 32(1), 2001, pp. 14-19
4. Moriette, G; Brunhes, A; Laffont, M; Coffinieres, A; Desfrere, L; Jarreau, PH
   Management of respiratory distress syndrome: An update
   PEDIATRIC PULMONOLOGY
   
   G. Moriette et al., "Management of respiratory distress syndrome: An update", PEDIAT PULM, 2001, pp. 100-102
5. Kastenbauer, T; Sauseng, S; Sokol, G; Auinger, M; Irsigler, K
   A prospective study of predictors for foot ulceration in type 2 diabetes
   JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
   
   T. Kastenbauer et al., "A prospective study of predictors for foot ulceration in type 2 diabetes", J AM POD M, 91(7), 2001, pp. 343-350
6. de Franchis, R; Dell'Era, A; Fazzini, L; Zatelli, S; Savojardo, V; Primignani, M
   Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when
   DIGESTIVE AND LIVER DISEASE
   
   R. de Franchis et al., "Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when", DIG LIVER D, 33(8), 2001, pp. 643-646
7. Biasco, G; Gallerani, E
   Treatment of liver metastases from colorectal cancer: what is the best approach today?
   DIGESTIVE AND LIVER DISEASE
   
   G. Biasco e E. Gallerani, "Treatment of liver metastases from colorectal cancer: what is the best approach today?", DIG LIVER D, 33(5), 2001, pp. 438-444
8. Puoti, M; Cadeo, GP; Putzolu, V; Forleo, MA; Barni, MC; Cristini, G; Rossi, S; Spinetti, A; Zaltron, S; Zanini, B; Quiros-Roldan, E; Paraninfo, G; Gargiulo, F; Carosi, G
   Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone
   DIGESTIVE AND LIVER DISEASE
   
   M. Puoti et al., "Pilot dose-finding trial on interferon alpha in combination with ribavirinfor the treatment of chronic hepatitis C in patients not responding to interferon alone", DIG LIVER D, 33(2), 2001, pp. 163-172
9. Cavallini, G; Frulloni, L
   Somatostatin and octreotide in acute pancreatitis: the never-ending story
   DIGESTIVE AND LIVER DISEASE
   
   G. Cavallini e L. Frulloni, "Somatostatin and octreotide in acute pancreatitis: the never-ending story", DIG LIVER D, 33(2), 2001, pp. 192-201
10. Leitman, M; Peleg, E; Rosenblat, S; Sucher, E; Wolf, R; Sedanko, S; Krakover, R; Vered, Z
    Transesophageal echocardiography - An overview
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    M. Leitman et al., "Transesophageal echocardiography - An overview", ISR MED ASS, 3(3), 2001, pp. 198-206
11. Psyrri, A; Murren, J
    Small cell lung cancer: Strategies to optimize chemotherapy response
    CANCER JOURNAL
    
    A. Psyrri e J. Murren, "Small cell lung cancer: Strategies to optimize chemotherapy response", CANCER J, 7, 2001, pp. S28-S34
12. Porte, RJ; Slooff, MJH
    Aprotinin: Safe and effective in all patients undergoing orthotopic liver transplantation?
    LIVER TRANSPLANTATION
    
    R.J. Porte e M.J.H. Slooff, "Aprotinin: Safe and effective in all patients undergoing orthotopic liver transplantation?", LIVER TRANS, 7(9), 2001, pp. 808-810
13. Kneteman, NM
    Steroid-free immunosuppression: Balancing efficacy and toxicity
    LIVER TRANSPLANTATION
    
    N.M. Kneteman, "Steroid-free immunosuppression: Balancing efficacy and toxicity", LIVER TRANS, 7(8), 2001, pp. 698-700
14. Neal, DAJ; Gimson, AES; Gibbs, P; Alexander, GJM
    Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight
    LIVER TRANSPLANTATION
    
    D.A.J. Neal et al., "Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight", LIVER TRANS, 7(6), 2001, pp. 533-539
15. Wiesner, R; Rabkin, J; Klintmalm, G; McDiarmid, S; Langnas, A; Punch, J; McMaster, P; Kalayoglu, M; Levy, G; Freeman, R; Bismuth, H; Neuhaus, P; Mamelok, R; Wang, W
    A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primaryliver transplant recipients
    LIVER TRANSPLANTATION
    
    R. Wiesner et al., "A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primaryliver transplant recipients", LIVER TRANS, 7(5), 2001, pp. 442-450
16. Alpen, B; Thiede, C; Wundisch, T; Bayerdorffer, E; Stolte, M; Neubauer, A
    Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy
    CLINICAL LYMPHOMA
    
    B. Alpen et al., "Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy", CLIN LYMPHO, 2(2), 2001, pp. 103-108
17. Arko, FR; Rubin, GD; Johnson, BL; Hill, BB; Fogarty, TJ; Zarins, CK
    Type-II endoleaks following endovascular AAA repair: Preoperative predictors and long-term effects
    JOURNAL OF ENDOVASCULAR THERAPY
    
    F.R. Arko et al., "Type-II endoleaks following endovascular AAA repair: Preoperative predictors and long-term effects", J ENDOVAS T, 8(5), 2001, pp. 503-510
18. Smith, SR; Kirking, DM
    The effect of insurance coverage changes on drug utilization in HIV disease
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S.R. Smith e D.M. Kirking, "The effect of insurance coverage changes on drug utilization in HIV disease", J ACQ IMM D, 28(2), 2001, pp. 140-149
19. Vittinghoff, E; Hessol, NA; Becchetti, P; Fusaro, RE; Holmberg, SD; Buchbinder, SP
    Cofactors for HIV disease progression in a cohort of homosexual and bisexual men
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E. Vittinghoff et al., "Cofactors for HIV disease progression in a cohort of homosexual and bisexual men", J ACQ IMM D, 27(3), 2001, pp. 308-314
20. Tarwater, PM; Margolick, JB; Jin, JH; Phair, JP; Detels, R; Rinaldo, C; Giorgi, J; Munoz, A
    Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P.M. Tarwater et al., "Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy", J ACQ IMM D, 27(2), 2001, pp. 168-175
21. Naidu, R; Bailey, SR
    Go with the flow?
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    R. Naidu e S.R. Bailey, "Go with the flow?", CATHET C IN, 54(3), 2001, pp. 376-377
22. Harding, SA; McKenna, CJ; Flapan, AD; Boon, NA
    Long-term clinical safety and efficacy of NIROYAL vs. NIR intracoronary stent
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    S.A. Harding et al., "Long-term clinical safety and efficacy of NIROYAL vs. NIR intracoronary stent", CATHET C IN, 54(2), 2001, pp. 141-145
23. Schobel, WA; Spyridopoulos, I; Hoffmeister, HM; Seipel, L
    Percutaneous coronary interventions using a new 5 french guiding catheter:Results of a prospective study
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    W.A. Schobel et al., "Percutaneous coronary interventions using a new 5 french guiding catheter:Results of a prospective study", CATHET C IN, 53(3), 2001, pp. 308-312
24. Eid-Lidt, G; Villavicencio-Fernandez, R; Ponce-de-Leon-Rosales, S; Gaspar, J; Luna-Guerra, J; Ban-Hayashi, E; Pena-Duque, MA; Martinez-Rios, MA
    Comparative trial of stent-like balloon angioplasty versus coronary stenting for acute myocardial infarction
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    G. Eid-Lidt et al., "Comparative trial of stent-like balloon angioplasty versus coronary stenting for acute myocardial infarction", CATHET C IN, 53(2), 2001, pp. 149-154
25. Shin, EK; Son, JW; Sohn, MS; Jin, DK; Park, GS; Koh, KK; Ahn, TH; Choi, IS
    Efficacy of heparin-coated stent in early setting of acute myocardial infarction
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    E.K. Shin et al., "Efficacy of heparin-coated stent in early setting of acute myocardial infarction", CATHET C IN, 52(3), 2001, pp. 306-312
26. Carey, D; Martin, JR; Moore, CA; Valentine, M; Nygaard, TW
    Complications of femoral artery closure devices
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    
    D. Carey et al., "Complications of femoral artery closure devices", CATHET C IN, 52(1), 2001, pp. 3-7
27. Flamm, BL
    Vaginal birth after caesarean (VBAC)
    BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    
    B.L. Flamm, "Vaginal birth after caesarean (VBAC)", BEST P R CL, 15(1), 2001, pp. 81-92
28. van Leerdam, ME; Rauws, EAJ
    The role of acid suppressants in upper gastrointestinal ulcer bleeding
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    M.E. van Leerdam e E.A.J. Rauws, "The role of acid suppressants in upper gastrointestinal ulcer bleeding", BEST PR RES, 15(3), 2001, pp. 463-475
29. Messmann, H
    Squamous cell cancer of the oesophagus
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    H. Messmann, "Squamous cell cancer of the oesophagus", BEST PR RES, 15(2), 2001, pp. 249-265
30. Salkowitz, JR; Purvis, SF; Meyerson, H; Zimmerman, P; O'Brien, TR; Aledort, L; Eyster, ME; Hilgartner, M; Kessler, C; Konkle, BA; White, GC; Goedert, JJ; Lederman, MM
    Characterization of high-risk HIV-1 seronegative hemophiliacs
    CLINICAL IMMUNOLOGY
    
    J.R. Salkowitz et al., "Characterization of high-risk HIV-1 seronegative hemophiliacs", CLIN IMMUNO, 98(2), 2001, pp. 200-211
31. Danchin, N
    Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    N. Danchin, "Recent advances in cardioprotection during myocardial revascularization procedures: benefit of a metabolic intervention", EUR H J SUP, 3(O), 2001, pp. O21-O25
32. Cruz-Fernandez, JM
    Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors
    EUROPEAN HEART JOURNAL SUPPLEMENTS
    
    J.M. Cruz-Fernandez, "Antiplatelet drugs in the treatment of acute coronary syndromes: Focus on cyclooxygenase inhibitors", EUR H J SUP, 3(I), 2001, pp. I23-I30
33. Bache, J
    Establishing an emergency nurse practitioner service
    EMERGENCY MEDICINE JOURNAL
    
    J. Bache, "Establishing an emergency nurse practitioner service", EMERG MED J, 18(3), 2001, pp. 186-189
34. Freeman, BD; Buchman, TG
    Interleukin-1 receptor antagonist as therapy for inflammatory disorders
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    B.D. Freeman e T.G. Buchman, "Interleukin-1 receptor antagonist as therapy for inflammatory disorders", EXPERT OP B, 1(2), 2001, pp. 301-308
35. McVicker, JT
    Blood pressure measurement - Does anyone do it right?: An assessment of the reliability of equipment in use and the measurement techniques of clinicians
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE
    
    J.T. McVicker, "Blood pressure measurement - Does anyone do it right?: An assessment of the reliability of equipment in use and the measurement techniques of clinicians", J FAM PLAN, 27(3), 2001, pp. 163-164
36. Davies, GR; Finch, RG
    Fever of unknown origin
    CLINICAL MEDICINE
    
    G.R. Davies e R.G. Finch, "Fever of unknown origin", CLIN MED, 1(3), 2001, pp. 177-179
37. Carruthers, DM
    Rational therapy in systemic necrotising vasculitis
    CLINICAL MEDICINE
    
    D.M. Carruthers, "Rational therapy in systemic necrotising vasculitis", CLIN MED, 1(1), 2001, pp. 7-9
38. Michailidis, GD; Spencer, K; Economides, DL
    The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's Syndrome
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    
    G.D. Michailidis et al., "The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down's Syndrome", BR J OBST G, 108(10), 2001, pp. 1047-1052
39. Rampaul, RS; Miremadi, A; Pinder, SE; Lee, A; Ellis, IO
    Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer
    BREAST CANCER RESEARCH
    
    R.S. Rampaul et al., "Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer", BREAST CA R, 3(2), 2001, pp. 113-116
40. Wyndaele, JJ
    The overactive bladder
    BJU INTERNATIONAL
    
    J.J. Wyndaele, "The overactive bladder", BJU INT, 88(2), 2001, pp. 135-140
41. Arnold, EP
    Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand
    BJU INTERNATIONAL
    
    E.P. Arnold, "Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand", BJU INT, 87(1), 2001, pp. 24-30
42. Michel, MC; Neumann, HG; Mehlburger, L; Schumacher, H; Goepel, M
    Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?
    BJU INTERNATIONAL
    
    M.C. Michel et al., "Does the time of administration (morning or evening) affect the tolerability or efficacy of tamsulosin?", BJU INT, 87(1), 2001, pp. 31-34
43. Deahl, M
    Pharmacological treatment of depression: the role of paroxetine
    HOSPITAL MEDICINE
    
    M. Deahl, "Pharmacological treatment of depression: the role of paroxetine", HOSP MED, 62(1), 2001, pp. 38-42
44. Furst, DE; Clements, PJ; Wong, WK; Mayes, MD; Wigley, F; White, B; Weisman, M; Barr, W; Moreland, L; Martin, R; Medsger, TA; Steen, V; Collier, D; Weinstein, A; Lally, E; Varga, J; Weiner, SR; Andrews, B; Abeles, M; Peter, JB; Seibold, JR
    Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial
    RHEUMATOLOGY
    
    D.E. Furst et al., "Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial", RHEUMATOLOG, 40(6), 2001, pp. 615-622
45. Konig, CW; Hahn, U; Tepe, G; Erley, CM; Schneider, W; Ritter, W; Beregi, JP; Goffette, P; Pereira, PL; Duda, SH
    Endovascular therapy for atherosclerotic renovascular disease: Technical results with the Palmaz (R)-Corinthian (TM) stent.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    C.W. Konig et al., "Endovascular therapy for atherosclerotic renovascular disease: Technical results with the Palmaz (R)-Corinthian (TM) stent.", ROFO-F RONT, 173(5), 2001, pp. 448-453
46. Manke, C; Hackethal, S; Muller-Hulsbeck, S; Djavidani, B; Heller, M; Link, J
    Results after placement of Memotherm stents in iliac and common femoral arteries.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
    
    C. Manke et al., "Results after placement of Memotherm stents in iliac and common femoral arteries.", ROFO-F RONT, 173(3), 2001, pp. 240-244
47. Muser, J; Bienvenu, J; Blanckaert, N; Brandslund, I; Delattre, J; Soffiati, G; Swaminathan, R; Maggini, S; Mastall, H
    Inter-laboratory evaluation of the COBAS INTEGRA (R) 400 analytical system
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    J. Muser et al., "Inter-laboratory evaluation of the COBAS INTEGRA (R) 400 analytical system", CLIN CH L M, 39(6), 2001, pp. 539-559
48. Scharnagl, H; Nauck, M; Wieland, H; Marz, W
    The Friedewald formula underestimates LDL cholesterol at low concentrations
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    H. Scharnagl et al., "The Friedewald formula underestimates LDL cholesterol at low concentrations", CLIN CH L M, 39(5), 2001, pp. 426-431
49. Bochicchio, R; Ponec, R; Torre, A; Lain, L
    Multicenter bonding within the AIM theory
    THEORETICAL CHEMISTRY ACCOUNTS
    
    R. Bochicchio et al., "Multicenter bonding within the AIM theory", THEOR CH AC, 105(4-5), 2001, pp. 292-298
50. Kulier, A
    Blood conservation in geriatric patients
    INFUSION THERAPY AND TRANSFUSION MEDICINE-INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    A. Kulier, "Blood conservation in geriatric patients", INFUS THER, 28(2), 2001, pp. 99-100
51. McMillan, RM
    Cysteinyl leukotriene antagonists
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    R.M. McMillan, "Cysteinyl leukotriene antagonists", PROG R RES, 31, 2001, pp. 111-114
52. Brane, G; Gottfries, CG; Winblad, B
    The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    G. Brane et al., "The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials", DEMENT G C, 12(1), 2001, pp. 1-14
53. Gaster, AL; Slothuus, U; Larsen, J; Thayssen, P; Haghfelt, T
    Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention
    SCANDINAVIAN CARDIOVASCULAR JOURNAL
    
    A.L. Gaster et al., "Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention", SC CARDIOVA, 35(2), 2001, pp. 80-85
54. Vanrenterghem, YFC
    Tailoring immunosuppressive therapy for renal transplant recipients
    PEDIATRIC TRANSPLANTATION
    
    Y.F.C. Vanrenterghem, "Tailoring immunosuppressive therapy for renal transplant recipients", PEDIAT TRAN, 5(6), 2001, pp. 467-472
55. Bucuvalas, JC; Ryckman, FC; Krug, S; Alonso, MH; Balistreri, WF; Kotagal, U
    Effect of treatment with prostaglandin E-1 and N-acetylcysteine on pediatric liver transplant recipients: A single-center study
    PEDIATRIC TRANSPLANTATION
    
    J.C. Bucuvalas et al., "Effect of treatment with prostaglandin E-1 and N-acetylcysteine on pediatric liver transplant recipients: A single-center study", PEDIAT TRAN, 5(4), 2001, pp. 274-278
56. Padua, L; Aprile, I; Caliandro, P; Carboni, T; Meloni, A; Massi, S; Mazza, O; Mondelli, M; Morini, A; Murasecco, D; Romano, M; Tonali, P
    Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy
    CLINICAL NEUROPHYSIOLOGY
    
    L. Padua et al., "Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy", CLIN NEU, 112(10), 2001, pp. 1946-1951
57. Omagari, K; Matsuo, I; Ohba, K; Masuda, J; Hazama, H; Sakimura, K; Kinoshita, H; Tsurutani, H; Isomoto, H; Murase, K; Kohno, S
    Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis
    HEPATOLOGY RESEARCH
    
    K. Omagari et al., "Synchronized disappearance of serum HCV-RNA, anti-U1 RNP, anti-La/SS-B, and anti-Scl-70 in a patient with chronic hepatitis", HEPATOL RES, 19(3), 2001, pp. 263-269
58. Hwang, SJ; Lee, SD; Chu, CW; Lu, RH; Chang, FY
    An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C
    HEPATOLOGY RESEARCH
    
    S.J. Hwang et al., "An open-label trial of consensus interferon 15 mu g in the treatment of Chinese patients with chronic hepatitis C", HEPATOL RES, 19(3), 2001, pp. 284-293
59. Wilson, JTL
    Assessing outcome in head injury trials
    CURRENT PHARMACEUTICAL DESIGN
    
    J.T.L. Wilson, "Assessing outcome in head injury trials", CUR PHARM D, 7(15), 2001, pp. 1537-1552
60. Durvasula, RS; Miller, EN; Myers, HF; Wyatt, GE
    Predictors of neuropsychological performance in HIV positive women
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
    
    R.S. Durvasula et al., "Predictors of neuropsychological performance in HIV positive women", J CL EXP N, 23(2), 2001, pp. 149-163
61. Ascioglu, S; De Pauw, BE; Donnelly, JP; Collette, L
    Reliability of clinical research on invasive fungal infections: a systematic review of the literature
    MEDICAL MYCOLOGY
    
    S. Ascioglu et al., "Reliability of clinical research on invasive fungal infections: a systematic review of the literature", MED MYCOL, 39(1), 2001, pp. 35-40
62. Cariski, AT
    Cilostazol: a novel treatment option in intermittent claudication
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    A.T. Cariski, "Cilostazol: a novel treatment option in intermittent claudication", INT J CL PR, 2001, pp. 11-18
63. Hiatt, WR
    New treatment options in intermittent claudication: the US experience
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    W.R. Hiatt, "New treatment options in intermittent claudication: the US experience", INT J CL PR, 2001, pp. 20-27
64. Peuskens, J; De Hert, M; Jones, M
    The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    
    J. Peuskens et al., "The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety", INT J PSYC, 5(3), 2001, pp. 179-187
65. Smits, HL; Chee, HD; Eapen, CK; Kuriakose, M; Sugathan, S; Gasem, MH; Yersin, C; Sakasi, D; Lai-a-Fat, RFM; Hartskeerl, RA; Liesdek, B; Abdoel, TH; Goris, MGA; Gussenhoven, GC
    Latex based, rapid and easy assay for human leptospirosis in a single testformat
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    H.L. Smits et al., "Latex based, rapid and easy assay for human leptospirosis in a single testformat", TR MED I H, 6(2), 2001, pp. 114-118
66. Hernandez, RH; Armas-Hernandez, MJ; Chourio, JAC; Armas-Padilla, MC; Lopez, L; Alvarez, M; Pacheco, B
    Comparative effects of amiodipine and nifedipine GITS during treatment andafter missing two doses
    BLOOD PRESSURE MONITORING
    
    R.H. Hernandez et al., "Comparative effects of amiodipine and nifedipine GITS during treatment andafter missing two doses", BL PRESS M, 6(1), 2001, pp. 47-57
67. Nordal, EJ; Moseng, D; Kvammen, B; Lochen, ML
    A comparative study of teleconsultations versus face-to-face consultations
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    E.J. Nordal et al., "A comparative study of teleconsultations versus face-to-face consultations", J TELEMED T, 7(5), 2001, pp. 257-265
68. van den Akker, TW; Reker, CHM; Knol, A; Post, J; Wilbrink, J; van der Veen, JPW
    Teledermatology as a tool for communication between general practitioners and dermatologists
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    T.W. van den Akker et al., "Teledermatology as a tool for communication between general practitioners and dermatologists", J TELEMED T, 7(4), 2001, pp. 193-198
69. Loane, MA; Oakley, A; Rademaker, M; Bradford, N; Fleischl, P; Kerr, P; Wootton, R
    A cost-minimization analysis of the societal costs of realtime teledermatology compared with conventional care: results from a randomized controlled trial in New Zealand
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    M.A. Loane et al., "A cost-minimization analysis of the societal costs of realtime teledermatology compared with conventional care: results from a randomized controlled trial in New Zealand", J TELEMED T, 7(4), 2001, pp. 233-238
70. Loane, MA; Bloomer, SE; Corbett, R; Eedy, DJ; Evans, C; Hicks, N; Jacklin, P; Lotery, HE; Mathews, C; Paisley, J; Reid, P; Steele, K; Wootton, R
    A randomized controlled trial assessing the health economics of realtime teledermatology compared with conventional care: an urban versus rural perspective
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    M.A. Loane et al., "A randomized controlled trial assessing the health economics of realtime teledermatology compared with conventional care: an urban versus rural perspective", J TELEMED T, 7(2), 2001, pp. 108-118
71. Williams, T; May, C; Esmail, A; Ellis, N; Griffiths, C; Stewart, E; Fitzgerald, D; Morgan, M; Mould, M; Pickup, L; Kelly, S
    Patient satisfaction with store-and-forward teledermatology
    JOURNAL OF TELEMEDICINE AND TELECARE
    
    T. Williams et al., "Patient satisfaction with store-and-forward teledermatology", J TELEMED T, 7, 2001, pp. S45-S46
72. Pangalis, GA; Dimopoulou, MN; Angelopoulou, MK; Tsekouras, C; Vassilakopoulos, TP; Vaiopoulos, G; Siakantaris, MP
    Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders - A review
    MEDICAL ONCOLOGY
    
    G.A. Pangalis et al., "Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders - A review", MED ONCOL, 18(2), 2001, pp. 99-107
73. Barbaro, G; Fisher, SD; Pellicelli, AM; Lipshultz, SE
    The expanding role of the cardiologist in the care of HIV infected patients
    HEART
    
    G. Barbaro et al., "The expanding role of the cardiologist in the care of HIV infected patients", HEART, 86(4), 2001, pp. 365-367
74. McLeod, AL; Northridge, DB; Uren, NG
    Ultrasound guided stenting
    HEART
    
    A.L. McLeod et al., "Ultrasound guided stenting", HEART, 85(6), 2001, pp. 605-606
75. Bigi, R; Desideri, A; Galati, A; Bax, JJ; Coletta, C; Fiorentini, C; Fioretti, PM
    Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction
    HEART
    
    R. Bigi et al., "Incremental prognostic value of stress echocardiography as an adjunct to exercise electrocardiography after uncomplicated myocardial infarction", HEART, 85(4), 2001, pp. 417-423
76. Dubrey, SW; Burke, MM; Khaghani, A; Hawkins, PN; Yacoub, MH; Banner, NR
    Long term results of heart transplantation in patients with amyloid heart disease
    HEART
    
    S.W. Dubrey et al., "Long term results of heart transplantation in patients with amyloid heart disease", HEART, 85(2), 2001, pp. 202-207
77. Pedersen, A
    LongoVital (R) and herpes labialis: a randomised, double-blind, placebo-controlled study
    ORAL DISEASES
    
    A. Pedersen, "LongoVital (R) and herpes labialis: a randomised, double-blind, placebo-controlled study", ORAL DIS, 7(4), 2001, pp. 221-225
78. Pedersen, A
    Topical treatment of recurrent herpes labialis
    ORAL DISEASES
    
    A. Pedersen, "Topical treatment of recurrent herpes labialis", ORAL DIS, 7(1), 2001, pp. 1-1
79. Femiano, F; Gombos, F; Scully, C
    Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir)
    ORAL DISEASES
    
    F. Femiano et al., "Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir)", ORAL DIS, 7(1), 2001, pp. 31-33
80. Midgley, R; Kerr, D
    Conventional cytotoxic and novel therapeutic concepts in colorectal cancer
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    R. Midgley e D. Kerr, "Conventional cytotoxic and novel therapeutic concepts in colorectal cancer", EXPERT OP I, 10(6), 2001, pp. 1011-1019
81. Emre, M; Qizilbash, N
    Experimental approaches and drugs in development for the treatment of dementia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M. Emre e N. Qizilbash, "Experimental approaches and drugs in development for the treatment of dementia", EXPERT OP I, 10(4), 2001, pp. 607-617
82. Diener, HC; Limmroth, V
    Advances in pharmacological treatment of migraine
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    H.C. Diener e V. Limmroth, "Advances in pharmacological treatment of migraine", EXPERT OP I, 10(10), 2001, pp. 1831-1845
83. Guttman, M; Jaskolka, J
    The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?
    PARKINSONISM & RELATED DISORDERS
    
    M. Guttman e J. Jaskolka, "The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?", PARKINS R D, 7(3), 2001, pp. 231-234
84. Khan, OA; Zvartau-Hind, M; Caon, C; Din, MU; Cochran, M; Lisak, D; Tselis, AC; Kamholz, JA; Garbern, JY; Lisak, RP
    Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy
    MULTIPLE SCLEROSIS
    
    O.A. Khan et al., "Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy", MULT SCLER, 7(3), 2001, pp. 185-188
85. Wolinksy, JS; Narayana, PA; Johnson, KP
    United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates
    MULTIPLE SCLEROSIS
    
    J.S. Wolinksy et al., "United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates", MULT SCLER, 7(1), 2001, pp. 33-41
86. McHutchison, JG; Shad, JA; Gordon, SC; Morgan, TR; Ling, MH; Garaud, JJ; Albrecht, JK; Dienstag, JL
    Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
    JOURNAL OF VIRAL HEPATITIS
    
    J.G. McHutchison et al., "Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy", J VIRAL HEP, 8(6), 2001, pp. 414-420
87. Scharrer, I; Ehrlich, HJ
    Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII
    HAEMOPHILIA
    
    I. Scharrer e H.J. Ehrlich, "Lack of evidence for increased inhibitor incidence in patients switched from plasma-derived to recombinant factor VIII", HAEMOPHILIA, 7(4), 2001, pp. 346-348
88. Mazzucconi, MG; Bizzoni, L; Giorgi, A; Morano, SG; Peraino, M; Russo, M; Alimena, G
    Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone
    HAEMOPHILIA
    
    M.G. Mazzucconi et al., "Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone", HAEMOPHILIA, 7(4), 2001, pp. 422-427
89. Yoneda, Y; Mori, E; Uehara, T; Yamada, O; Tabuchi, M
    Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital
    EUROPEAN JOURNAL OF NEUROLOGY
    
    Y. Yoneda et al., "Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital", EUR J NEUR, 8(5), 2001, pp. 483-488
90. Barnes, MP; Gilhus, NE; Wender, M
    Task force on minimum standards for health care of people with multiple sclerosis: June 1999
    EUROPEAN JOURNAL OF NEUROLOGY
    
    M.P. Barnes et al., "Task force on minimum standards for health care of people with multiple sclerosis: June 1999", EUR J NEUR, 8(3), 2001, pp. 215-220
91. Gruffyd-Jones, K; Kies, B; Middleton, A; Mulder, LJMM; Rosjo, O; Millson, DS
    Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study
    EUROPEAN JOURNAL OF NEUROLOGY
    
    K. Gruffyd-Jones et al., "Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study", EUR J NEUR, 8(3), 2001, pp. 237-245
92. Khan, OA; Tselis, AC; Kamholz, JA; Garbern, JY; Lewis, RA; Lisak, RP
    A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFN beta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis
    EUROPEAN JOURNAL OF NEUROLOGY
    
    O.A. Khan et al., "A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFN beta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis", EUR J NEUR, 8(2), 2001, pp. 141-148
93. Uter, W; Schnuch, A; Geier, J; Pfahlberg, A; Gefeller, O
    Association between occupation and contact allergy to the fragrance mix: amultifactorial analysis of national surveillance data
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    
    W. Uter et al., "Association between occupation and contact allergy to the fragrance mix: amultifactorial analysis of national surveillance data", OCC ENVIR M, 58(6), 2001, pp. 392-398
94. Taylor, R; Cumming, R; Woodward, A; Black, M
    Passive smoking and lung cancer: a cumulative meta-analysis
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
    
    R. Taylor et al., "Passive smoking and lung cancer: a cumulative meta-analysis", AUS NZ J PU, 25(3), 2001, pp. 203-211
95. Vanholder, R; Lameire, N
    Acute renal failure: future directions for research
    NEPHROLOGY
    
    R. Vanholder e N. Lameire, "Acute renal failure: future directions for research", NEPHROLOGY, 6(2), 2001, pp. 57-61
96. Barbosa, AP; Medina, JL; Ramos, EP; Barros, HP
    Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population
    DIABETES & METABOLISM
    
    A.P. Barbosa et al., "Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population", DIABETE MET, 27(4), 2001, pp. 496-502
97. Blajchman, MA; Hebert, PC
    Red blood cell transfusion strategies
    TRANSFUSION CLINIQUE ET BIOLOGIQUE
    
    M.A. Blajchman e P.C. Hebert, "Red blood cell transfusion strategies", TRANSF CL B, 8(3), 2001, pp. 207-210
98. Delmee, M
    Laboratory diagnosis of Clostridium difficile disease
    CLINICAL MICROBIOLOGY AND INFECTION
    
    M. Delmee, "Laboratory diagnosis of Clostridium difficile disease", CL MICRO IN, 7(8), 2001, pp. 411-416
99. Rementeria, A; Gallego, L; Quindos, G; Garaizar, J
    Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns
    CLINICAL MICROBIOLOGY AND INFECTION
    
    A. Rementeria et al., "Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns", CL MICRO IN, 7(6), 2001, pp. 331-336
100. Ishaq, S; Green, JRB
     Tolerability of aminosalicylates in inflammatory bowel disease
     BIODRUGS
     
     S. Ishaq e J.R.B. Green, "Tolerability of aminosalicylates in inflammatory bowel disease", BIODRUGS, 15(5), 2001, pp. 339-349